Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 1 2Phase EARLY_PHASE1 1Phase 3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2Breast 2Thoracic 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1

Conditions

Melanoma 2

Interventions

pembrolizumab 100Nivolumab 69Cyclophosphamide 67Ipilimumab 66fludarabine 34aldesleukin 29fludarabine phosphate 28Vemurafenib 28Interleukin-2 26trametinib 20Biopsy 20dabrafenib 17Radiotherapy 16Temozolomide 15Cisplatin 15Magnetic Resonance Spectroscopy 14Gemcitabine 14Filgrastim 14atezolizumab 13Specimen Handling 13Carboplatin 13CTLA-4 Antigen 13spartalizumab 12romidepsin 12Paclitaxel 12Bortezomib 11poly ICLC 10cobimetinib 10Peripheral Blood Stem Cell Transplantation 10Oxaliplatin 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Sentinel Lymph Node Biopsy × Dermatologic × Clear all
NCT02968680 2020-03-30

Sonazoid-Enhanced Ultrasound in Detecting Sentinel Lymph Node in Patients With Cutaneous Melanoma

University of Southern California

Phase 1 Terminated
5 enrolled
Dermatologic

Melanoma

NCT01121718 2017-02-03

NIR-Guided Sentinel Lymph Node Mapping in Melanoma

Dana-Farber Cancer Institute

Phase 1 Completed
26 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡